Mitsuru Obe
@mit_obe
@NikkeiAsia desk editor; former @WSJ
日本経済新聞
ID: 1602123180
18-07-2013 00:22:01
8,8K Tweet
3,3K Takipçi
715 Takip Edilen
Why are Japanese drug stocks seen as a haven despite a 25% tariff threat from Trump? For one, innovative patented drugs are not easily replaceable, making them more resilient to trade measures like tariffs. asia.nikkei.com/Business/Pharm… via Nikkei Asia